Preliminary study on efficacy and tolerance of a «coupage» of olive oil in patients with chronic kidney disease. Nutritional evaluation;Estudio preliminar sobre eficacia y tolerancia de un «coupage» de aceite de oliva en pacientes con enfermedad renal crónica. Evaluación del estado de nutrición

Nefrologia

Volumn 27, Issue 4, 2007, Pages 472-481

  Pérez Bañasco, Vicente ^a,h   Gil Cunquero, J M ^a   Borrego, F J ^a   Grassso M ^b   Segura, P ^a   Warletta, F ^c   Lozano, J L ^d   Costa, L A ^e,f   Torres, J ^g   Gaforio, J J ^c   Villarrubia, V G ^e,f  

^a Servicio de Nefrologia

^b CHUJ

^c UNIVERSITY OF JAÉN   (Spain)

^d Laboratorios Unaproliva   (Spain)

^e Dpto de I D i de Bioaveda Oncología   (Argentina)

^f Dpto de Inmunología Y Medicina Preventiva   (Spain)

^g Agropecuaria El Puerto ^*  (Spain)

^h Allergy Section   (Spain)

Author keywords

OHo ; Chronic kidney disease; HOMA; Inflamation; Malnutrition; Olive oil

Indexed keywords

OLIVE OIL; VEGETABLE OIL;

ARTICLE; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; FEMALE; HUMAN; INFLAMMATION; KIDNEY DISEASE; MALE; MALNUTRITION; MIDDLE AGED; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL;

CHRONIC DISEASE; FEMALE; HUMANS; INFLAMMATION; KIDNEY DISEASES; MALE; MALNUTRITION; MIDDLE AGED; PILOT PROJECTS; PLANT OILS;

EID: 38449096279     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81: 543-54, 2005.
2. Lim VS, Kopple JD: Protein metabolism in patients with chronic renal failure: role of uremia and dialysis. Kidney Int 58: 1-10, 2000.
3. Ikizler TA: Protein and energy: recommended intake and nutrient supplementation in chronic dialysis patients. Semin Dial 17: 471-8, 2004.
4. Mitch WE: Proteolytic mechanisms, not malnutrition, causes loss of muscle mass in kidney failure. J Ren Nutr 16: 208-11, 2006.
5. Kaysen GA, Dubin JA, Muller HG, Rosales L, Levin NW, Mitch WE; HEMO Study Group NIDDK: Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int 65: 1408-15, 2004.
6. Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, y cols.: Correction of metabolic acidosis increases serum albumin concentration and decreases kinetically evaluated protein intake in hemodialysis patients: a prospective study. Nephrol Dial Transplant 13: 1719-22, 1998.
7. Arima H, Nakamoto H, Okada S, Inoue T, Kobayashi K, Shoda J y cols.: Risk factors for vascular complications in patients on peritoneal dialysis. Adv Perit Dial 22: 22: 192-7, 2006.
8. Cooper BA, Penne EL, Bartlett LH, Pollock CA: Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 43: 61-6, 2004.
9. Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, Himmelfarb J: Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis 42: 286-94, 2003.
10. Pupim LB, Majchrzak KM, Flakoll PJ, Ikizler TA: Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status. J Am Soc Nephrol 17: 3149-57, 2006.
11. Leon JB, Albert JM, Gilchrist G, Kushner I, Lerner E, Mach S y cols.: Improving albumin levels among hemodialysis patients: a community-based randomised-controlled trial. Am J Kidney Dis 48: 28-36, 2006.
12. Kalantar-Zadeh K, Braglia A, Chow J, Kwon O, Kuwae N, Colman S y cols.: An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: a pilot/feasibility study. J Ren Nutr 15: 318-31, 2005.
13. Cano NJM, Saingra Y, Dupuy AM, Lorec-Penet AM, Porugal H, Lairon D y cols.: Intradialytic parenteral nutrition: comparison of olive oil versus soybean oil-based lipid emulsions. Br J Nutr 95: 152-9, 2006.
14. Pérez-Jiménez F: International Conference on the healthy effects of virgin olive oil. Eur J Clin Invest 35: 421-4, 2005.
15. Marrugat J, Covas MI, Fito M, Schroder H, Miró-Casas E, Gimeno E y cols.: Effects of differing phenolic content in dietary olive oil on lipids and LDL oxidation: a randomized controlled trial. Eur J Nutr 43: 140-7, 2004.
16. Weinbrenner T, Fitó M, De la Torre R, Sáez GT, Rijken P, Tormos C y cols.: Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men. J Nutr 134: 2314-21, 2004.
17. Cullinen K: Olive oil in the treatment of hypercholesterolemia. Med Health RI 89: 113, 2006.
18. Gardner CD, Kraemer HC: Monounsaturated versus polyunsaturated dietary fat and serum lipids. Artherioscler Thromb Vasc Biol 15: 1917-27, 1995.
19. Mensink RP, Katan MB: Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 12: 911-9, 1992.
20. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ: Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71: 1085-94, 2000.
21. Pedersen A, Baumstark MW, Marckmann P, Gylling H, Sandström B: An olive oil-rich diet results in higher concentrations of LDL cholesterol and a higher number of LDL subfraction particles than rapeseed oil and sunflower oil diets. J Lipid Res 41: 1901-11, 2000.
22. Svensson M, Christensen JH, Solling J, Schmidt EB: The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF. Am J Kidney Dis 44: 77-83, 2004.
23. Garg A: High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 67 (3 Supl.): 577S-82S, 1998.
24. Rivellese AA, De Natale C, Lilli S: Type of dietary fat and insulin resistance. Ann NY Acad Sci 967: 329-35, 2002.
25. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G y cols.: Effect of a mediterranean-style diet on endotelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292: 1440-6, 2004.
26. Pérez-Martínez P, Pérez-Jiménez F, Bellido C, Ordovás JM, Moreno JA, Marín C y cols.: A polymorphism exon 1 variant at the locus of the scavenger receptor class B type I (SCARB1) gene is associated with differences in insulin sensitivity in healthy people during the consumption of an olive oil-rich diet. J Clin Endocrinol Metab 90: 2297-300, 2005.
27. Mayer-Davis EJ, Monaco JH, Hoen HM, Carmichael S, Vitolins MZ, Rewers MJ y cols.: Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS). Am J Clin Nutr 65: 79-87, 1997.
28. Risérus U, Vessby B, Arnlov J, Basu S: Effect of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 80: 279-83, 2004.
29. Larsen TM, Toubro S, Gudmundsen O, Astrup A: Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. Am J Clin Nutr 83: 606-12, 2006.
30. Whitehead SA, Rice S: Endocrine-disrupting chemicals as modulators of sex steroid synthesis. Best Pract Res Clin Endocrinol Metab 20: 45-61, 2006.
31. Cabras P, Caboni P, Cabras M, Angioni A, Russo M: Rotenone residues on olives and in olive oil. J Agric Food Chem 50: 2576-80, 2002.
32. Dahl NV: Herbs and supplements in dialysis patients: panacea or poison? Semin Dial 14: 186-92, 2001.
33. Gracia-Trabanino R, Domínguez J, Jansa JM, Oliver A. Proteinuria y fallo renal crónico en la costa de El Salvador: detección con métodos de bajo coste y factores asociados. Nefrología 25: 31-8, 2005.
34. Burrowes JD, Van Houten G: Use of alternative medicine by patients with stage 5 chronic kidney disease. Adv Chronic Kidney Dis 12: 312-25, 2005.
35. Villarrubia VG, González Álvarez P, Costa LA, Torres Morales J: ¿Aceite de oliva o aceites de oliva? El error de creer que solo hay un aceite de oliva. Información técnica sobre composición química y repercusiones del aceite de oliva sobre la salud humana. (Accesible desde 2006 en: http: //www.bioaveda.com/salud/ aceitesoaceites.pdf).
36. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J y cols.: Definition and classification of chronic kidney disease: a position statement from Kideney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-100, 2005.
37. Ministerio de Agricultura, Pesca y Alimentación. Subdirección General de Planificación Alimentaria. I.1. Disposiciones generales relativas a los aceites vegetales comestibles. Disposiciones comunitarias. (Disponible en: http: //www.mapa.es/alimentacion/ pags/calidad/aceites/pdf/I1.pdf).
38. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-9, 1985.
39. Cano N, Labastie-Coeyrehoucq J, Lacombe P, Stroumza P, Di Costanzo-Dufetel J, Durbec JP y cols.: Perdialytic parenteral nutrition with lipids and amino-acids in malnourished hemodialyzed patients. Am J Clin Nutr 52: 726-30, 1990.
40. Czekalski S, Hozejowski R: Intradialytic amino acids supplementation in hemodialysis patients with malnutrition: results of a multicenter cohort study. J Ren Nutr 14: 82-8, 2004.
41. Cano N, Luc G, Stroumza P, Lacombe P, Durbec JP: Serum lipoprotein changes after prolonged Intralipid, infusion in malnourished hemodialysis patients. Clin Nutr 13: 111-5, 1994.
42. Kaysen GA: Dyslipidemia in chronic kidney disease: causes and consequences. Kidney Int 70 (S104): S55-S58, 2006.